Ming‐Chi Lu
Impact in
- Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research
- Physiology top 0.5%
- Alzheimer's disease research and treatments
Papers in
- Rheumatology 72
- Rheumatoid Arthritis Research and Therapies 41
- Systemic Lupus Erythematosus Research 27
- Spondyloarthritis Studies and Treatments 20
-
- Dementia and Cognitive Impairment Research 28
- Co-authors
- Ning‐Sheng Lai (79 shared papers)Mark A. Mintun (25 shared papers)Michael J. Pontecorvo (27 shared papers)Abhinay D. Joshi (16 shared papers)Malcolm Koo (51 shared papers)Tzung‐Yi Tsai (50 shared papers)Daniel Skovronsky (9 shared papers)Hanoch Livneh (44 shared papers)
- Journals
- Alzheimer s & Dementia (10 papers)PLoS ONE (10 papers)International Journal of Molecular Sciences (7 papers)BMJ Open (7 papers)Frontiers in Medicine (6 papers)
- Partner nations
- TaiwanUnited StatesCanada
In The Last Decade
Ming‐Chi Lu
249 papers receiving 8.2k citations
Ming‐Chi Lu's Hit Papers
Peers
Comparison fields: 5 of 155
- Psychiatry and Mental health 2.3k
- Physiology 2.4k
- Biological Psychiatry 194
- Rheumatology 964
- Neurology 485
Countries citing papers authored by Ming‐Chi Lu
This map shows the geographic impact of Ming‐Chi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chi Lu more than expected).
Fields of papers citing papers by Ming‐Chi Lu
This network shows the impact of papers produced by Ming‐Chi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chi Lu. The network helps show where Ming‐Chi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Chi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 265 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Donanemab in Early Symptomatic Alzheimer Disease Hit paper breakdown → | 2023 | 1732 |
| 2 | Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study Hit paper breakdown → | 2012 | 706 |
| 3 | Positron Emission Tomography Imaging With [ 18 F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes Hit paper breakdown → | 2020 | 344 |
| 4 | 2013 | 338 | |
| 5 | 2017 | 306 | |
| 6 | 2005 | 274 | |
| 7 | 2013 | 213 | |
| 8 | 2014 | 174 | |
| 9 | 2022 | 153 | |
| 10 | 2016 | 125 | |
| 11 | 2012 | 116 | |
| 12 | 2012 | 108 | |
| 13 | 2012 | 106 | |
| 14 | 2010 | 105 | |
| 15 | 2013 | 91 | |
| 16 | 2009 | 86 | |
| 17 | 2013 | 83 | |
| 18 | 2015 | 78 | |
| 19 | 2016 | 78 | |
| 20 | 2015 | 77 |
About Ming‐Chi Lu
Ming‐Chi Lu is a scholar working on Rheumatology, Psychiatry and Mental health, Physiology, Immunology and Cancer Research, having authored 265 papers that have together received 8.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (41 papers), Dementia and Cognitive Impairment Research (28 papers), Systemic Lupus Erythematosus Research (27 papers), Alzheimer's disease research and treatments (24 papers), Spondyloarthritis Studies and Treatments (20 papers), Salivary Gland Disorders and Functions (14 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Psychiatry and Mental health (2.3k citations), Physiology (2.4k citations), Biological Psychiatry (194 citations), Rheumatology (964 citations) and Neurology (485 citations). Ming‐Chi Lu has collaborated with scholars based in Taiwan, United States and Canada. Frequent co-authors include Ning‐Sheng Lai, Mark A. Mintun, Michael J. Pontecorvo, Abhinay D. Joshi, Malcolm Koo, Tzung‐Yi Tsai, Daniel Skovronsky, Hanoch Livneh, Adam Fleisher and Chia‐Li Yu. Their work appears in journals such as Alzheimer s & Dementia, PLoS ONE, International Journal of Molecular Sciences, BMJ Open and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.